(19)
(11) EP 4 581 629 A1

(12)

(43) Date of publication:
09.07.2025 Bulletin 2025/28

(21) Application number: 23768624.1

(22) Date of filing: 01.09.2023
(51) International Patent Classification (IPC): 
G16B 40/20(2019.01)
(52) Cooperative Patent Classification (CPC):
G16B 40/20
(86) International application number:
PCT/IB2023/058673
(87) International publication number:
WO 2024/047608 (07.03.2024 Gazette 2024/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 02.09.2022 US 202263403652 P

(71) Applicant: Janssen Research & Development, LLC
Raritan, New Jersey 08869 (US)

(72) Inventors:
  • RAMON, Albert Juan
    Raritan, New Jersey 08869 (US)
  • STANDISH, Kristopher
    Raritan, New Jersey 08869 (US)
  • PARMAR, Chaitanya
    Raritan, New Jersey 08869 (US)
  • LUTNICK, Brendon
    Raritan, New Jersey 08869 (US)
  • YIP, Stephen
    Raritan, New Jersey 08869 (US)
  • GINLEY, Brandon
    Raritan, New Jersey 08869 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) METHODS AND SYSTEMS FOR AI-BASED IMMUNE PROFILING FOR CANCER PATIENT STRATIFICATION